{"id":"W2947750347","doi":"10.1200/jco.2019.37.15_suppl.5551","title":"Efficacy of maintenance olaparib for newly diagnosed, advanced ovarian cancer patients (pts) by BRCA1 or BRCA2 mutation in the phase III SOLO1 trial.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Medicine; Internal medicine; Oncology; Ovarian cancer; Placebo; BRCA mutation; Progression-free survival; Cancer; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009250574,0.0008447957,0.00108611,0.0002060223,0.0002037756,0.0007609737,0.0004470522,0.0006596259,0.003267954],"category_scores_gemma":[0.0007693149,0.0003237225,0.001314858,0.0002308943,0.0004016154,0.0005028532,0.0002895043,0.001554411,0.0004034562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005835726,"about_ca_system_score_gemma":0.0006550333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003259643,"about_ca_topic_score_gemma":0.001256781,"domain_scores_codex":[0.9997707,0.0001148537,0.00001585503,0.00004397264,0.00001956238,0.00003511681],"domain_scores_gemma":[0.9995456,0.00009064152,0.0001370903,0.00002664934,0.00001853765,0.0001812677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9119411,0.004197672,0.006133422,0.001038245,0.0016068,0.0001318536,0.0001119029,0.0009645699,0.00881806,0.0002397641,0.003109948,0.06170661],"study_design_scores_gemma":[0.8811959,0.1007862,0.01079415,0.000134027,0.001235496,0.0003030458,0.00004655343,0.001014166,0.001407091,0.0003577889,0.002701629,0.00002395515],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98607,0.008831637,0.0002885443,0.000724361,0.0001420359,0.0008157482,0.001266927,0.00005262772,0.001808168],"genre_scores_gemma":[0.9914792,0.002720441,0.0005226629,0.0008223958,0.0001462873,0.001019574,0.001896241,0.00001125221,0.001381915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003267954,"threshold_uncertainty_score":0.01093239,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09327385480056455,"score_gpt":0.4985404147317112,"score_spread":0.4052665599311467,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}